BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19171049)

  • 1. Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry.
    Rothwangl KB; Rong L
    Virol J; 2009 Jan; 6():12. PubMed ID: 19171049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
    Rothwangl KB; Manicassamy B; Uprichard SL; Rong L
    Virol J; 2008 Mar; 5():46. PubMed ID: 18355410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.
    Russell RS; Kawaguchi K; Meunier JC; Takikawa S; Faulk K; Bukh J; Purcell RH; Emerson SU
    J Viral Hepat; 2009 Sep; 16(9):621-32. PubMed ID: 19302336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
    Drummer HE; Boo I; Maerz AL; Poumbourios P
    J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.
    Lavie M; Sarrazin S; Montserret R; Descamps V; Baumert TF; Duverlie G; Séron K; Penin F; Dubuisson J
    J Virol; 2014 Sep; 88(18):10584-97. PubMed ID: 24990994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry.
    Ciczora Y; Callens N; Penin F; Pécheur EI; Dubuisson J
    J Virol; 2007 Mar; 81(5):2372-81. PubMed ID: 17166909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.
    Owsianka AM; Timms JM; Tarr AW; Brown RJ; Hickling TP; Szwejk A; Bienkowska-Szewczyk K; Thomson BJ; Patel AH; Ball JK
    J Virol; 2006 Sep; 80(17):8695-704. PubMed ID: 16912317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.
    Qin ZL; Ju HP; Gao TT; Wang WB; Ren H; Zhao P; Qi ZT
    J Gen Virol; 2015 Jun; 96(Pt 6):1389-1399. PubMed ID: 25701820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
    Keck ZY; Li SH; Xia J; von Hahn T; Balfe P; McKeating JA; Witteveldt J; Patel AH; Alter H; Rice CM; Foung SK
    J Virol; 2009 Jun; 83(12):6149-60. PubMed ID: 19321602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse CD81 proteins support hepatitis C virus infection.
    Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA
    J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry.
    Li HF; Huang CH; Ai LS; Chuang CK; Chen SS
    J Biomed Sci; 2009 Sep; 16(1):89. PubMed ID: 19778418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
    Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
    Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins.
    Kalemera MD; Capella-Pujol J; Chumbe A; Underwood A; Bull RA; Schinkel J; Sliepen K; Grove J
    J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33147126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.
    Moustafa RI; Haddad JG; Linna L; Hanoulle X; Descamps V; Mesalam AA; Baumert TF; Duverlie G; Meuleman P; Dubuisson J; Lavie M
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
    Cowton VM; Angus AGN; Cole SJ; Markopoulou CK; Owsianka A; Dunlop JI; Gardner DE; Krey T; Patel AH
    J Virol; 2016 Aug; 90(16):7456-7468. PubMed ID: 27279607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function.
    McCaffrey K; Boo I; Tewierek K; Edmunds ML; Poumbourios P; Drummer HE
    J Virol; 2012 Apr; 86(7):3961-74. PubMed ID: 22278231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.
    Fraser J; Boo I; Poumbourios P; Drummer HE
    J Biol Chem; 2011 Sep; 286(37):31984-92. PubMed ID: 21768113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.
    Lavillette D; Pécheur EI; Donot P; Fresquet J; Molle J; Corbau R; Dreux M; Penin F; Cosset FL
    J Virol; 2007 Aug; 81(16):8752-65. PubMed ID: 17537855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
    Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
    J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.